134 related articles for article (PubMed ID: 9776270)
21. Effect of metabolic substrate on BMIPP metabolism in canine myocardium.
Nohara R; Hosokawa R; Hirai T; Okuda K; Ogino M; Fujibayashi Y; Fujita M; Sasayama S
J Nucl Med; 1998 Jul; 39(7):1132-7. PubMed ID: 9669382
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of fatty acid metabolism in hearts after ischemia-reperfusion injury using a dual-isotope autoradiographic approach and tissue assay for metabolites of tracer.
Igarashi N; Nozawa T; Fujii N; Kato B; Nonomura M; Matsuki A; Nakadate T; Igawa A; Asanoi H; Inoue M; Inoue H
J Nucl Med; 2005 Jan; 46(1):160-4. PubMed ID: 15632047
[TBL] [Abstract][Full Text] [Related]
23. Fatty acid kinetics in aerobic myocardium: characteristics of tracer carbon entry and washout and influence of metabolic demand.
Nellis SH; Liedtke AJ; Renstrom B
J Nucl Med; 1992 Oct; 33(10):1864-74. PubMed ID: 1403160
[TBL] [Abstract][Full Text] [Related]
24. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
[TBL] [Abstract][Full Text] [Related]
25. Distribution of carbon flux within fatty acid utilization during myocardial ischemia and reperfusion.
Nellis SH; Liedtke AJ; Renstrom B
Circ Res; 1991 Sep; 69(3):779-90. PubMed ID: 1873872
[TBL] [Abstract][Full Text] [Related]
26. Quantitation of myocardial fatty acid metabolism using PET.
Bergmann SR; Weinheimer CJ; Markham J; Herrero P
J Nucl Med; 1996 Oct; 37(10):1723-30. PubMed ID: 8862319
[TBL] [Abstract][Full Text] [Related]
27. Preliminary evaluation of 15-[18F]fluoro-3-oxa-pentadecanoate as a PET tracer of hepatic fatty acid oxidation.
DeGrado TR; Wang S; Rockey DC
J Nucl Med; 2000 Oct; 41(10):1727-36. PubMed ID: 11038005
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of radioiodinated fatty acid myocardial imaging agents in animal models and human studies.
Knapp FF; Kropp J; Franken PR; Visser FC; Sloof GW; Eisenhut M; Yamamichi Y; Shirakami Y; Kusuoka H; Nishimura T
Q J Nucl Med; 1996 Sep; 40(3):252-69. PubMed ID: 8961803
[TBL] [Abstract][Full Text] [Related]
29. Myocardial metabolism of 123I-BMIPP in a canine model with ischemia: implications of perfusion-metabolism mismatch on SPECT images in patients with ischemic heart disease.
Hosokawa R; Nohara R; Fujibayashi Y; Okuda K; Ogino M; Hirai T; Fujita M; Tamaki N; Konishi J; Sasayama S
J Nucl Med; 1999 Mar; 40(3):471-8. PubMed ID: 10086713
[TBL] [Abstract][Full Text] [Related]
30. Increased nonoxidative glycolysis despite continued fatty acid uptake during demand-induced myocardial ischemia.
Chandler MP; Huang H; McElfresh TA; Stanley WC
Am J Physiol Heart Circ Physiol; 2002 May; 282(5):H1871-8. PubMed ID: 11959654
[TBL] [Abstract][Full Text] [Related]
31. Metabolic mismatch of septal beta-oxidation and glucose utilization in left bundle branch block assessed with PET.
Altehoefer C; vom Dahl J; Bares R; Stöcklin GL; Büll U
J Nucl Med; 1995 Nov; 36(11):2056-9. PubMed ID: 7472598
[TBL] [Abstract][Full Text] [Related]
32. Liver uptake of free fatty acids in vivo in humans as determined with 14( R, S)-[18F]fluoro-6-thia-heptadecanoic acid and PET.
Iozzo P; Turpeinen AK; Takala T; Oikonen V; Solin O; Ferrannini E; Nuutila P; Knuuti J
Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1160-4. PubMed ID: 12811532
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of trans-9-18F-fluoro-3,4-Methyleneheptadecanoic acid as a PET tracer for myocardial fatty acid imaging.
Shoup TM; Elmaleh DR; Bonab AA; Fischman AJ
J Nucl Med; 2005 Feb; 46(2):297-304. PubMed ID: 15695790
[TBL] [Abstract][Full Text] [Related]
34. 17-[4-(2-[18F]fluoroethyl)-1H-1,2,3-triazol-1-yl]-6-thia-heptadecanoic acid: a potential radiotracer for the evaluation of myocardial fatty acid metabolism.
Kim DH; Choe YS; Choi JY; Choi Y; Lee KH; Kim BT
Bioconjug Chem; 2009 Jun; 20(6):1139-45. PubMed ID: 19530707
[TBL] [Abstract][Full Text] [Related]
35. Assessment of myocardial metabolism with iodine-123 heptadecanoic acid: effect of decreased fatty acid oxidation on deiodination.
Lüthy P; Chatelain P; Papageorgiou I; Schubiger A; Lerch RA
J Nucl Med; 1988 Jun; 29(6):1088-95. PubMed ID: 3373317
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and tissue distribution of fluorine-18 labeled trifluorohexadecanoic acids. Considerations in the development of metabolically blocked myocardial imaging agents.
Pochapsky SS; VanBrocklin HF; Welch MJ; Katzenellenbogen JA
Bioconjug Chem; 1990; 1(4):231-44. PubMed ID: 2096916
[TBL] [Abstract][Full Text] [Related]
37. Fundamental limitations of [18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake.
Hariharan R; Bray M; Ganim R; Doenst T; Goodwin GW; Taegtmeyer H
Circulation; 1995 May; 91(9):2435-44. PubMed ID: 7729031
[TBL] [Abstract][Full Text] [Related]
38. The contribution of glycolysis, glucose oxidation, lactate oxidation, and fatty acid oxidation to ATP production in isolated biventricular working hearts from 2-week-old rabbits.
Itoi T; Lopaschuk GD
Pediatr Res; 1993 Dec; 34(6):735-41. PubMed ID: 8108185
[TBL] [Abstract][Full Text] [Related]
39. Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion: implications for clinical SPECT.
Hosokawa R; Nohara R; Fujibayashi Y; Okuda K; Ogino M; Hata T; Fujita M; Tamaki N; Konishi J; Sasayama S
J Nucl Med; 1997 Dec; 38(12):1857-63. PubMed ID: 9430458
[TBL] [Abstract][Full Text] [Related]
40. Myocardial extraction of 1-[11C] betamethylheptadecanoic acid.
Elmaleh DR; Livni E; Alpert NM; Strauss HW; Buxton R; Fischman AJ
J Nucl Med; 1994 Mar; 35(3):496-503. PubMed ID: 8113905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
